Full article: Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas
Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non–Small Cell Lung Carcinomas - Modern Pathology
Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment:
Molecular Diagnostics for Lung Cancer | SpringerLink
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of
From Traditional Histology to Next-Generation Pathology: A Review of The Workflow for the Characterisation and Molecular Profiling of Non-Small Cell Lung Cancer Samples - European Medical Journal
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for
Molecular testing - Clinical Lab Products
Oncogenic Drivers in Advanced NSCLC: Navigating an Evolving Landscape to Optimise Patient Outcomes - European Medical Journal
JMP | Free Full-Text | What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy
A narrative review of cancer molecular diagnostics: past, present, and future | Journal of Bio-X Research
Importance of testing | NSCLC testing with broad molecular profiling
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
JMP | Free Full-Text | Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
2nd 1:15 1:17
Diagnostics | Free Full-Text | Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
Authors' Reply
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibi
PDF) LYNX (LYmphoid NeXt-generation sequencing) panel: a comprehensive capture-based sequencing tool for the analysis of prognostic and predictive markers in lymphoid malignancies
Diagnostics | Free Full-Text | The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization
PDF) Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013
Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer | Scientific Reports
ONCOLOGY: Molecular Testing in NSCLC – References
Optimizing Biomarker Testing in Advanced Non-Small Cell Lung Cancer - Cancer Therapy Advisor
Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms | Modern Pathology
The basics of commonly used molecular techniques for diagnosis, and application of molecular testing in cytology - Turner - 2023 - Diagnostic Cytopathology - Wiley Online Library
